Endocrine Abstracts

Contents

• 19th European Congress of Endocrinology 2017
• • Prize Lectures and Biographical Notes
  • The European Journal of Endocrinology Prize Lecture
  • • Hypothalmic AMPK: a golden target against obesity?

      ea0049eje1
    • European Journal of Endocrinology Prize Winner

      ea0049eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Toward hormone-based precision medicines for metabolic diseases

      ea0049gh1
    • Geoffrey Harris Prize Winner

      ea0049gh1biog
  • European Hormone Medal Lecture
  • • Endocrine disruptors: Is it all Greek to us?

      ea0049ehm1
    • European Hormone Medal Lecture

      ea0049ehm1biog
  • Clinical Endocrinology Trust Lecture
  • • Prospects for a new assessment of polycystic ovarian syndrome

      ea0049cet1
    • Clinical Endocrinology Trust Lecture

      ea0049cet1biog
  • IPSEN1
  • • Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation

      ea0049ipsen1
• Plenary Lectures
• • The fantastical world of hormones
  • • The fantastical world of hormones

      ea0049p1
  • The secret life of FGF21
  • • The secret life of FGF21

      ea0049p2
  • Update on regulation of steroidogenesis by aberrant hormone receptors
  • • Update on regulation of steroidogenesis by aberrant hormone receptors

      ea0049p3
  • The role of brain insulin resistance for the development of prediabetic phenotypes
  • • The role of brain insulin resistance for the development of prediabetic phenotypes

      ea0049p4
  • Browning of adipose tissue and metabolic regulation
  • • Browning of adipose tissue and metabolic regulation

      ea0049p5
  • Thyroid oncology in the crossroads of precision and narrative medicine
  • • Thyroid oncology in the crossroads of precision and narrative medicine

      ea0049p6
• Symposia
• • Clinical Updates in Hypoparathyroidism
  • • Congenital hypoparathyroidism

      ea0049s1.1
    • Acquired hypoparathyroidism

      ea0049s1.2
    • Clinical updates in hypoparathyroisism

      ea0049s1.3
  • Evolving diagnostics in adrenal and neuroendocrine tumours
  • • Role of genetic and biomarker tests for diagnosis of neuroendocrine tumours (NETs)

      ea0049s2.1
    • Current status in morphological imaging in adrenal and gastrointestinal neuroendocrine tumours

      ea0049s2.2
    • Current status in functional imaging

      ea0049s2.3
  • From the pituitary to the periphery
  • • Implication of the prolactin receptor in humans

      ea0049s3.1
    • GHR: are there benefits of endocrine defects?

      ea0049s3.2
    • Somatostatin receptors: news in the pituitary, lessons for the periphery

      ea0049s3.3
  • 2nd Joint Global Symposium on Obesity - The Many Dimensions of the Childhood Obesity Problem
  • • Efficacy and effectiveness of physical activity and nutrition interventions in childhood obesity treatment

      ea0049s4.1
    • The hunger genes: pathways to obesity

      ea0049s4.2
    • Can we prevent childhood obesity?

      ea0049s4.3
  • Turn your face to the sunshine
  • • Effects of maternal thyroid function on infant neurodevelopment

      ea0049s5.1
    • Vitamin D and rickets in African children

      ea0049s5.2
    • Carbohydrate metabolism in patients with Cushing disease: a glance at the incretin system

      ea0049s5.3
  • Treatment of hypothyroidism: what have we learned?
  • • What is the clinical relevance of deiodinase polymorphisms?

      ea0049s6.1
    • T4/T3 combination therapy: is there a true effect?

      ea0049s6.2
    • Rebuilding your own thyroid from stem cells; the future therapy of hypothyroidism?

      ea0049s6.3
  • Crosstalk between bone & other organ(ism)s
  • • Immune system

      ea0049s7.1
    • Osteocalcin signaling in myofibers is necessary and sufficient to increase exercise capacity

      ea0049s7.2
    • Gut microbiota and bone metabolism

      ea0049s7.3
  • Predictors of therapeutic response in functioning pituitary tumours
  • • Molecular profiling

      ea0049s8.1
    • MRI predictors of therapeutic response in GH-secreting pituitary tumours

      ea0049s8.2
    • Predictors of therapeutic response in functioning pituitary tumours

      ea0049s8.3
  • Novel type 2 diabetes treatment: Beyond glycaemic control
  • • Experimental models

      ea0049s9.1
    • Clinical studies on GLP1 - cardiovascular outcomes

      ea0049s9.2
    • SGLT2 long term protective effects

      ea0049s9.3
  • The Challenges of Male Fertility
  • • Manipulating testicular androgen production to promote lifelong male health

      ea0049s10.1
    • Fertility preservation in pre-pubertal and young males

      ea0049s10.2
    • Pubertal induction and hormone replacement in young males

      ea0049s10.3
  • New Roles for Nuclear Receptors
  • • Identification of nuclear receptors network in male fertility

      ea0049s11.1
    • Crosstalk between estrogen signalling and DNA damage repair

      ea0049s11.2
    • The role of androgens in bone

      ea0049s11.3
  • New development in Graves' Orbitopathy
  • • The orbital fibroblast: a key player and target for therapy in graves' orbitopathy

      ea0049s12.1
    • Management of Graves orbitopathy

      ea0049s12.2
    • How to predict progression in Graves orbitopathy?

      ea0049s12.3
  • Challenging pituitary diseases
  • • Hypophysitis

      ea0049s13.1
    • Empty sella

      ea0049s13.2
    • Imaging of sellar masses

      ea0049s13.3
  • Searching for the cause and approach in ectopic hormone syndromes
  • • Rare Cushing's

      ea0049s14.1
    • Searching for the cause and approach in ectopic hormone syndromes: rare acromegaly

      ea0049s14.2
    • Rare hypoglycemia

      ea0049s14.3
  • Metabolic surgery mechanisms to clinical results (Endorsed by the European Journal of Endocrinology)
  • • The upper gut anti-incretin theory

      ea0049s15.1
    • The role of bile in metabolic surgery

      ea0049s15.2
    • Long term effects of metabolic surgery

      ea0049s15.3
  • Late-breaking: the PCSK9 revolution
  • • Beyond LDL lowering: the pleiotropic roles of PCSK9

      ea0049s16.1
    • New strategies for inhibiting PCSK9

      ea0049s16.2
    • PCSK9 inihibition in clinical practice: present and future

      ea0049s16.3
  • What endocrinologists should know about the genomics of endocrine tumors
  • • Clinical consequences of the recent genomics findings in thyroid cancer

      ea0049s17.1
    • Clinical implications of SDHx mutations

      ea0049s17.2
    • Will genomics help to finally classify NET's?

      ea0049s17.3
  • Hyperandrogenism: challenges in clinical management
  • • Hyperandrogenic states: pitfalls in diagnostic approach

      ea0049s18.1
    • Metabolic perspectives for the non-classical CAH (NCAH)

      ea0049s18.2
    • Hyperandrogenism and cardiometabolic risk

      ea0049s18.3
  • How to incorporate the new guidelines for thyroid cancer in my clinical practice
  • • Thyroid microcarcinoma: to treat or not to treat?

      ea0049s19.1
    • When and how should we perform extensive surgery?

      ea0049s19.2
    • Dynamic risk stratification in low-risk vs high-risk patients

      ea0049s19.3
  • Beta cell replacement and plasticity (Endorsed by Endocrine Connections)
  • • Stem cells for [beta] cell replacement in type 1 diabetes

      ea0049s20.1
    • New Strategies for beta cell replacement

      ea0049s20.2
    • Induction of pancreatic beta-like cell neogenesis

      ea0049s20.3
  • Environmental influences on endocrine systems
  • • Lifestyle and environmental factors in metabolic diseases; endocrine disruptors: new diabetogens?

      ea0049s21.1
    • Evidence on reproductive disorders through endocrine disruption in-utero

      ea0049s21.2
    • Euthyroid: towards a euthyroid Europe

      ea0049s21.3
  • Rare bone diseases (Endorsed by the European Journal of Endocrinology)
  • • Approach for clinicians

      ea0049s22.1
    • Osteogenesis imperfecta & Ehlers-Danlos Syndrome

      ea0049s22.2
    • Fibrous dysplasia of bone/McCune-Albright syndrome

      ea0049s22.3
  • Endo Oncology: prolactin, GH and metabolic hormones in oncology pathogenesis (Endorsed by Endocrine Connections)
  • • Prolactin regulation of prostate stem cells: potential implications in prostate cancer

      ea0049s23.1
    • Is GH a cancer growth factor?

      ea0049s23.2
    • Is reducing insulin-resistance relevant to prevent cancer?

      ea0049s23.3
  • Obesity: Pharmacological solutions
  • • MSH analogs

      ea0049s24.1
    • The future drugs to come

      ea0049s24.2
    • US experience update

      ea0049s24.3
  • HPA axis regulation during a woman's life: impact on metabolic outcomes
  • • HPA axis regulation during a woman's life: impact on metabolic outcomes

      ea0049s25.1
    • HPA axis, insulin resistance and adipocytokines in the fetal-maternal unit

      ea0049s25.2
    • 11[beta]-hydroxysteroid dehydrogenase activity, androgen excess, and metabolic outcomes in woman

      ea0049s25.3
  • Tissue specific defects in thyroid hormone action
  • • Mouse models to study tissue specific hypothyroidism

      ea0049s26.1
    • Syndromes of decreased sensitivity to thyroid hormone

      ea0049s26.2
    • Restoring TH action in patients with transporter defects: the triac trial

      ea0049s26.3
  • Vitamin D beyond bone (Endorsed by Endocrine Connections)
  • • Heart & Vessels

      ea0049s27.1
    • Fertility

      ea0049s27.2
    • Muscles

      ea0049s27.3
  • Sleep, love and reproduction (Endorsed by Endocrine Connections)
  • • Candidate mechanisms underlying the association between poor sleep and obesity

      ea0049s28.1
    • Oxytocin: from biology to love

      ea0049s28.2
    • Kisspeptin and neurokinin B - novel reproductive hormones with therapeutic potential

      ea0049s28.3
  • Novel predictors of diabetes
  • • Novel predictors of type 1 diabetes

      ea0049s29.1
    • Clinical and genetic indicators for diabetes prediction

      ea0049s29.2
    • Novel predictors of diabetes - NAFLD, diabetes and CVD

      ea0049s29.3
  • Moving away from old-fashioned steroidogenesis: what are the clinical implications?
  • • Clinical relevance of alternative synthesis of androgens

      ea0049s30.1
    • Clinical relevance of steroid precursors in adrenocortical tumors

      ea0049s30.2
    • Glucocorticoid production in primary aldosteronism - from mechanisms to clinical implications

      ea0049s30.3
  • Guided session 1
  • • New international clinical practice guidelines for the care of girls and women with turner syndrome

      ea0049gs1.1
    • Growth and puberty induction

      ea0049gs1.2
    • Adult aspects of turner syndrome

      ea0049gs1.3
    • Cardiovascular health issues in turner syndrome

      ea0049gs1.4
    • Abstract unavailable

      ea0049gs1.5
    • Abstract unavailable

      ea0049gs1.6
  • Guided session 2
  • • Aggressive pituitary tumours

      ea0049gs2.1
    • Aggressive pituitary tumours

      ea0049gs2.2
    • Aggressive pituitary tumours

      ea0049gs2.3
    • Aggressive pituitary tumours

      ea0049gs2.4
    • Aggressive pituitary tumours

      ea0049gs2.5
    • Aggressive pituitary tumours

      ea0049gs2.6
• New Scientific Approaches
• • (1)
  • • Identifying molecular signatures for cancer patient stratification via metabolomics and integrative bioinformatics

      ea0049nsa1
    • Exosome profiling: potential in cancer diagnosis and stratification

      ea0049nsa2
    • Genomic approaches on epigenetics

      ea0049nsa3
    • CRISPR/cas9 cas9-generated mouse models of resistance to thyroid hormone due to THRA mutations

      ea0049nsa4
    • Methodical tools for the structural elucidation of G-protein coupled receptors

      ea0049nsa5.1
    • Small molecule agonists and antagonists as potential new therapeutics targeting the TSH receptor

      ea0049nsa5.2
    • Mitochondrial epigenetics in obesity and its co-diseases

      ea0049nsa6
• DEBATES
• • Is there a role for medical therapy for non-functioning pituitary adenomas?
  • • Is there a role for medical therapy for non- functioning pituitary adenomas? - FOR

      ea0049d1.1
    • Is there a role for medical therapy for non- functioning pituitary adenomas? - AGAINST

      ea0049d1.2
  • Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? (Endorsed by the European Journal of Endocrinology)
  • • Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? - FOR

      ea0049d2.1
    • Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? - AGAINST

      ea0049d2.2
  • Drug holiday in osteoporosis (Endorsed by the European Journal of Endocrinology)
  • • Drug holiday in osteoporosis - FOR

      ea0049d3.1
    • Drug holiday in osteoporosis - AGAINST

      ea0049d3.2
  • Is cardiovascular risk increased in women with PCOS?
  • • Is cardiovascular risk increased in women with PCOS? - FOR

      ea0049d4.1
    • Is cardiovascular risk increased in women with PCOS? - AGAINST

      ea0049d4.2
  • Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer?
  • • Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer? - FOR

      ea0049d5.1
    • Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer? - AGAINST

      ea0049d5.2
  • Is it time for initial combination in type 2 diabetes?
  • • Is it time for initial combination in type 2 diabetes? - FOR

      ea0049d6.1
    • Is it time for initial combination in type 2 diabetes? - AGAINST

      ea0049d6.2
• Meet the Expert Sessions
• • (1)
  • • How to manage diabetes in the elderly?

      ea0049mte1
    • Diagnosis and management of GH deficiency - from childhood to adulthood

      ea0049mte2
    • Hormone-secreting adrenal tumours in pregnancy

      ea0049mte3
    • Treatment of congenital hypothyroidism

      ea0049mte4
    • Modern spectrum of bone turnover markers - are they clinically useful?

      ea0049mte5
    • How best to utilise technology in diabetes?

      ea0049mte6
    • When and which treatment to use in Graves disease?

      ea0049mte7
    • How best to manage neuroendocrine tumours? - Towards a new algorithm

      ea0049mte8
    • Sarcopenia - why should we care?

      ea0049mte9
    • Contraception in women with obesity, metabolic syndrome and diabetes

      ea0049mte10
    • Drug induced osteoporosis

      ea0049mte11
    • A modern approach for treatment PCOS

      ea0049mte12
    • What can new insulins provide for management of diabetes?

      ea0049mte13
    • Thyroid carcinoma: complicated cases

      ea0049mte14
    • Gaucher disease: interdisciplinary management

      ea0049mte15
    • New treatment approaches in dyslipidemia

      ea0049mte16
    • A paediatric perspective of endocrine late complications following childhood cancer

      ea0049mtne1
    • Providing nursing care for the adult patient with endocrine late effects of cancer treatment

      ea0049mtne2
    • Unravelling the role of transient receptor potential channels in endocrine regulation and metabolism

      ea0049mtbs1
    • Regulation and dysregulation of appetite and satiety

      ea0049mtbs2
    • MicroRNAs and the regulation of glucose and lipid metabolism

      ea0049mtbs3
• Nurse Sessions
• • (1)
  • • Clinical practice overlap and seamless care - diagnosis and management of hypothyroidism in patients with diabetes mellitus

      ea0049n1.1
    • Clinical practice overlap and seamless care - links between hypogonadism, the metabolic syndrome and type 2 diabetes

      ea0049n1.2
    • Clinical practice overlap and seamless care - challenges in the management of patients with Cushing's syndrome and diabetes

      ea0049n1.3
    • Clinical practice overlap and seamless care - at risk of two endocrine emergencies: the patient with type 1 diabetes and Addison's disease

      ea0049n1.4
    • Nurses professional development and networking session - obstructive sleep apnea and comorbidities in patients with pituitary adenomas

      ea0049n2.1
    • Nurses professional development and networking session - utilising the competence framework to develop the role of endocrine nurses in adrenal insufficiency

      ea0049n2.2
    • Nurses professional development and networking session - hybrid training of nurses in/for the endocrinology; train the trainer with help of e-learning modules

      ea0049n2.3
    • Nurses professional development and networking session - developing a European position statement for endocrine nurses providing care for patients with adrenal insufficiency

      ea0049n2.4
    • Update on diet and lifestyle throughout lifespan to improve health - prevalance and treatment of vitamin D deficieny in children

      ea0049n3.1
    • Update on diet and lifestyle throughout lifespan to improve health - sexual hormones and bone, a close link throughout lifespan

      ea0049n3.2
    • Update on diet and lifestyle throughout lifespan to improve health - osteoporosis and prevention of fractures: nurses can a play key role

      ea0049n3.3
• Oral Communications
• • Adrenal-Basic & Clinical
  • • High resolution tissue mass spectrometry imaging: a new tool for identification of prognostic markers in adrenocortical carcinoma

      ea0049oc1.1
    • EZH2: a master regulator of adrenal cortex homeostasis and zonation

      ea0049oc1.2
    • Steroid metabolomics for accurate and rapid diagnosis of inborn steroidogenic disorders

      ea0049oc1.3
    • The epidemiology of pheochromocytoma: increasing incidence and changing clinical presentation. A population-based retrospective study 1977-2015

      ea0049oc1.4
    • Diagnostic accuracy of three confirmatory tests for primary aldosteronism: a prospective study and systematic review

      ea0049oc1.5
  • Diabetes Prediction and Complications
  • • microRNA expression profile in plasma from patients with type 1 diabetes: a case-control study and bioinformatics analysis

      ea0049oc2.1
    • Effectiveness of complex therapy in patients with comorbidity of type 2 diabetes and essential hypertension depending on genetic polymorphism PPAR[gamma]2

      ea0049oc2.2
    • GLP-1 based multi-agonists-induced signaling includes profound TRP channel involvement in insulin secretion

      ea0049oc2.3
    • Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial

      ea0049oc2.4
    • Urinary peptidomics for the detection of diabetic kidney disease

      ea0049oc2.5
  • Receptors & Signalling
  • • Epigenetic regulation of aldosterone synthase gene, CYP11B2 by potassium

      ea0049oc3.1
    • Elucidating the role of Liver X receptors (LXRs) in the testis using lipid systems biology

      ea0049oc3.2
    • AKR1C3-mediated adipose androgen generation drives lipotoxicity in polycystic ovary syndrome

      ea0049oc3.3
    • Treatment with thyroid hormone metabolite 3,5-T2 alters cholesterol and sex steroid metabolism in mouse liver

      ea0049oc3.4
    • Accurate staging of non-alcoholic fatty liver disease through analysis of the urinary steroid metabolome

      ea0049oc3.5
  • Thyroid Disease 1
  • • Hypothyroidism in pregnancy is associated with twin pregnancies and with adverse obstetric outcome: Analysis of 142,277 deliveries data from a single center

      ea0049oc4.1
    • Inducible thyrocyte-specific Gs alpha-deficient mice as a novel model for hypothyroidism

      ea0049oc4.2
    • A novel variant in the SERPINA7 gene causing partial TBG deficiency in a women and two male siblings: molecular and protein structural analysis

      ea0049oc4.3
    • The TSH receptor reaches the trans-Golgi network to induce PKA activation and trigger gene transcription

      ea0049oc4.4
    • Levothyroxine replacement therapy: once treatment is started, should it last indefinitely?

      ea0049oc4.5
  • Cardiovascular Endocrinology
  • • Polarized epithelial cells release exosomes loaded with miRNAs capable of interacting with HSD11B2 and MR genes

      ea0049oc5.1
    • Association of PPAR gamma gene expression with dietary intake of fat and oil among non-diabetic subjects

      ea0049oc5.2
    • Cardio metabolic assessment of lamin A/C mutation carriers according to R482 or Non-R482 mutation

      ea0049oc5.3
    • Food history characterization of Portuguese centenarians, nutritional biomarkers and cardiovascular risk: case control study

      ea0049oc5.4
    • Sex dimorphism of renal corticosteroid signaling during development and long term consequence on blood pressure

      ea0049oc5.5
  • Diabetes therapy and complications
  • • A passe-PAR2 for [beta]-cell regeneration and protection

      ea0049oc6.1
    • Insulin-mimetic effects of short-term Rapamycin in type 1 diabetic patients prior islet transplantation

      ea0049oc6.2
    • Alterations in DNA methylation from peripheral blood cells in humans threated with metformin

      ea0049oc6.3
    • Copeptin and its association to cardiovascular dysfunction in type 2 diabetes

      ea0049oc6.4
    • Activation of the Renin-Angiotensin II-Aldosterone-System leads to increases in extracellular protein disulfide isomerase: role in insulin resistance

      ea0049oc6.5
  • Cardiovascular endocrinology (1)
  • • Estrogens enhance gonadectomy-induced adrenocortical tumor progression in mice

      ea0049oc7.1
    • Targeted molecular markers derived from genomic classification for adrenocortical cancer prognostication

      ea0049oc7.2
    • High Total 68Ga-DOTATATE-Avid Tumor Volume (TV) is associated with low progression-free survival and high disease-specific mortality rate in patients with neuroendocrine tumors

      ea0049oc7.3
    • A novel insight into the anticancer mechanism of metformin in Pancreatic Neuroendocrine Tumor cells

      ea0049oc7.4
    • Regulation of steroid receptor signalling by tumor suppressor INPP4B

      ea0049oc7.5
  • Neuroendocrinology
  • • Elucidating the molecular mechanisms underlying AIP dependent tumorigenesis

      ea0049oc8.1
    • Knocking down/out the prokineticin pathway during zebrafish development results in the GnRH neurons axons misguiding

      ea0049oc8.2
    • RNA sequencing and RT-qPCR identify different gene expression profiles in fast- vs. slow-growing non-functioning pituitary adenomas

      ea0049oc8.3
    • Cerebrovascular stroke incidence in GH-treated adults: experience from KIMS (Pfizer International Metabolic Database)

      ea0049oc8.4
    • Ephrin-B2 is required for pituitary development

      ea0049oc8.5
  • Thyroid Disease 2
  • • Thyroid function and metabolic syndrome: results from the population-based LifeLines Cohort study

      ea0049oc9.1
    • Effect of restoration of euthyroidism in patients with hypothyroidism on cold induced thermogenesis

      ea0049oc9.2
    • How much of the genetic predisposition to Hashimoto's thyroiditis can be explained by genes commonly associated with the disease?

      ea0049oc9.3
    • Thyroid dysfunction during the use of PD-1/PD-L1 blockade predicts its therapeutic response in the patients with advanced non-small cell lung cancer

      ea0049oc9.4
    • Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the 'Serena Study' a randomized, double-blind, placebo-controlled trial

      ea0049oc9.5
  • Bone & Calcium Homeostasis
  • • Treatment of 711 patients with hypoparathyroidism: a retrospective study in 3 German endocrine centres

      ea0049oc10.1
    • Evaluation of bone quality, measured by trabecular bone score (TBS) in patients with primary hyperparathyroidism (PHH) with and without surgery

      ea0049oc10.2
    • High prevalence of radiological vertebral fractures in patients with differentiated thyroid carcinoma undergoing L-thyroxine TSH-suppressive therapy

      ea0049oc10.3
    • The effect of denosumab or bisphosphonates in women with severe postmenopausal osteoporosis after completion of teriparatide treatment

      ea0049oc10.4
    • G[alpha]11-Phe220Ser loss-of-function mutation causes familial hypocalciuric hypercalcemia type-2 (FHH2) by disrupting a hydrophobic cluster critical for G-protein signaling

      ea0049oc10.5
  • Obesity
  • • Role of Extracellular vesicles in the crosstalk between adipocytes and pancreatic beta-cells

      ea0049oc11.1
    • Three year prospective study in morbidly obese patients between longitudinal gastrectomy and gastric bypass based on a composite outcome combining weight loss efficacy and surgery related complications (PHRC SLEEVE K060213 / IDRCB2007-A00373-50)

      ea0049oc11.2
    • Interleukin-1 antagonism decreases cortisol levels in obese individuals

      ea0049oc11.3
    • Comparing effects of weight loss by liraglutide with intensive lifestyle modification on hepatic steatosis, inflammation and stiffness, and insulin resistance in obese Asians with non-alcoholic fatty liver disease (NAFLD)

      ea0049oc11.4
    • Differentiating constitutional thinness from anorexia nervosa in DSM 5 era

      ea0049oc11.5
  • Pituitary Clinical
  • • T2-Weighted signal intensity of functional pituitary adenomas: correlation with clinicopathological findings and response to treatment

      ea0049oc12.1
    • Use of temozolomide in a large cohort of patients with aggressive pituitary tumours and pituitary carcinomas: Results from a European Society of Endocrinology (ESE) survey

      ea0049oc12.2
    • Recombinant Growth Hormone added to physical therapy in GH-deficient adults with complete (ASIA A) Spine Injury (EudraCT 2011-005377-23)

      ea0049oc12.3
    • Subclinical cardiovascular system dysfunction in the patients with Cushing's disease

      ea0049oc12.4
    • Effects of pegvisomant and somatostatin receptor ligands on risk of vertebral fractures in patients with Acromegaly

      ea0049oc12.5
  • Reproduction & Endocrine Disruption
  • • Abstract unavailable

      ea0049oc13.1
    • Thyroid peroxidase antibodies do not predict outcome in 900 women with recurrent pregnancy loss

      ea0049oc13.2
    • Sertoli cell expressed hydroxysteroid (17beta) dehydrogenase 1 is required for male fertility

      ea0049oc13.3
    • Diabetes mellitus: a new cause of male infertility

      ea0049oc13.4
    • Urinary cadmium excretion is associated with increased synthesis of cortico- and sex steroids in a family-based Swiss population study

      ea0049oc13.5
  • Thyroid Cancer
  • • Anti-Mullerian hormone (AMH) in pre-menopausal females after ablative radioiodine (RAI) treatment for differentiated thyroid cancer (DTC): single-center study

      ea0049oc14.1
    • Suppression of heme oxygenase-1 inhibits growth and invasion of thyroid cancer

      ea0049oc14.2
    • TERT, BRAF and NRAS in the molecular profile of metastatic thyroid cancer: differences between primary and distant disease

      ea0049oc14.3
    • Inverse relation between thyroid cancer incidence and threshold for thyroid surgery: a national population-based retrospective study

      ea0049oc14.4
    • Dose aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classical papillary carcinoma?

      ea0049oc14.5
• Guided Posters
• • Adrenal 1
  • • PRKACA mutations in adrenal Cushing can alter substrate specificity

      ea0049gp1
    • Contribution of retinoic acid receptor signalling to adrenal cortex morphology and functional zonation through modulation of WNT/[beta]-catenin pathway

      ea0049gp2
    • Exosomal hsa-miR-483-5p and hsa-miR-101 are potential minimally invasive biomarkers of adrenocortical carcinoma

      ea0049gp3
    • Androgen receptor signalling is essential for regression of the adrenal x-zone and regulation of the adrenal cortex in the male mouse

      ea0049gp4
    • Protein Kinase A signaling saves regulatory subunit II[beta] from PRKACA mutation-mediated degradation

      ea0049gp5
    • Involvement of ARMC5 in proliferation and cell cycle control of human cell cultures from adrenal nodules of primary macronodular adrenocortical hyperplasia (PMAH)

      ea0049gp6
    • Identification of a new glucocorticoid receptor mutation underscores the substantial prevalence of genetic NR3C1 alterations in adrenal hyperplasia: the French National Research Program MUTA-GR

      ea0049gp7
    • Clinical and translational relevance of circulating miR483 in adrenocortical cancer

      ea0049gp8
    • Mortality is increased in patients with Cushing's disease in long-term remission: A nation-wide study

      ea0049gp9
    • Expression of GATA transcription factors and their role in the aetiology of Testicular Adrenal Rest Tumours

      ea0049gp10
  • Adrenal 2
  • • A country comparison of glucocorticoid replacement therapy in patients with primary and secondary adrenal insufficiency: data from the EU-AIR

      ea0049gp11
    • Activation of the cAMP/PKA transduction system triggers abnormal expression of the serotonin signaling pathway in human adrenocortical cells

      ea0049gp12
    • PRKARIA (Carney complex gene) is a major regulator of the tight link between cell cycle phases and steroidogenesis in the adrenocortical tumor cells H295R

      ea0049gp13
    • Simultaneous assays of aldosterone and renin concentrations in just ten minutes could change the clinical assessment for the diagnosis of primary aldosteronism

      ea0049gp14
    • Integrated genomic and phenomic analysis reveals key molecular pathways of aldosterone producing adenoma

      ea0049gp15
    • Cardiovascular features of autonomous cortisol secretion in patients with adrenal incidentalomas

      ea0049gp16
    • Hypercortisolism is prevalent in newly diagnosed type 2 diabetes: a prospective study of 384 consecutive patients

      ea0049gp17
    • Effects of two mineralocorticoid receptor antagonists on the morphology of the adrenal cortex

      ea0049gp18
    • Plasma cortisol and aldosterone responses to insulin tolerance test and sodium depletion in women with non classic 21-hydroxylase deficiency caused by bi-allelic CYP21A2 mutations (NC-CAH)

      ea0049gp19
    • Which are the factors and causes of death in patients with adrenal insufficiency? Mortality data from EU-AIR

      ea0049gp20
  • Adrenal 3
  • • Is diabetes mellitus associated with catecholamine-secreting tumours always a secondary diabetes?

      ea0049gp21
    • Epithelial to mesenchymal transition in adrenocortical tumours: focus on FGF-FGFR pathway and c-MET

      ea0049gp22
    • Clinical features and treatment outcomes in a group of SDHx-related pheochromocytoma/paraganglioma patients

      ea0049gp23
    • Increased exosomes in endogeneous Cushing syndrome

      ea0049gp24
    • Tumor microenvironment increases migration/invasion of murine pheochromocytoma SDHB silenced spheroids

      ea0049gp25
    • Metformin reduces viability and proliferation of pheochromocytoma cells in vitro

      ea0049gp26
    • The role of in vivo metabolomics using H-MRS in SDH deficient disease

      ea0049gp27
    • A PRKACB somatic mutation in a cortisol producing adenoma: a new example of protein kinase A activation leading to adrenal Cushing syndrome

      ea0049gp28
    • Familial case of SDHB mutation presenting as a macroprolactinoma

      ea0049gp29
    • Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with cyclical ectopic adrenocorticotrophic hormone secretion

      ea0049gp30
    • Long-term treatment of acute ectopic ACTH syndrome with Etomidate

      ea0049gp31
    • Multiple pathologic fractures as the presenting manifestation of Cushing's syndrome in patients with vitamin D receptor FokI gene polymorphism

      ea0049gp32
  • Bone & Calcium Homeostasis 1
  • • [ldquo]Hyperparanet[rdquo]: a multicenter Italian study on Primary Hyperparathyroidism

      ea0049gp33
    • Fat mass distribution and resistin are independent predictors of bone mass in postmenopausal, but not premenopausal women.

      ea0049gp34
    • Aldosterone and parathyroid hormone - is there a connection?

      ea0049gp35
    • Relationship between circulating microRNAs and bone mineral density in patients with active acromegaly

      ea0049gp36
    • Effects of BCR-ABL targeted tyrosine kinase inhibitors on the whole transcriptome pattern of cultured murine osteoblasts

      ea0049gp37
    • Decreased trabecular bone score but not bone mineral density in patients with acromegaly and concurrent hypogonadism: cross-sectional study with healthy controls

      ea0049gp38
    • Association of changes in serum urate level and bone mineral density during treatment with teriparatide: a retrospective observational study

      ea0049gp39
    • Coexistence of primary hyperparathyroidism with papillary thyroid carcinoma: a case series

      ea0049gp40
    • Follow-up of patients with surgical hypoparathyroidism: unknown cause of renal function decline?

      ea0049gp41
    • Expression of hypoxia-inducible factor-1[alpha] in Calbindin-D9k Knockout mice

      ea0049gp42
  • Bone & Calcium Homeostasis 2
  • • Chromosome 2q37 microdeletions in two cases of sporadic PHP-1B with broad GNAS imprinting defects

      ea0049gp43
    • Investigation of total and free 25OHD vitamin levels in patients with chronic renal failure on different dose of cholecalciferol

      ea0049gp44
    • Methylation patterns at the novel DMR of GNAS (GNAS-AS2) in pseudohypoparathyroidism 1B (PHP1B or iPPSD3) subtypes

      ea0049gp45
    • Vitamin D correction elevates apolipoprotein levels in a sex-specific manner

      ea0049gp46
    • Recombinant human parathyroid hormone (rhPTH[1-84], parathyroid hormone rDNA) improves hypercalciuria in patients with hypoparathyroidism: 3-year analysis from RACE study

      ea0049gp47
    • Vitamin D levels after 4 weeks of very low calorie diet (VLCD)

      ea0049gp48
    • Upper gastrointestinal symptoms, endoscopic and pathological features, and serum gastrin and chromogranin A levels in patients with primary hyperparathyroidism

      ea0049gp49
    • Localisation of parathyroid adenomas using 11C-methionine-PET/CT when conventional imaging methods are negative

      ea0049gp50
    • Calcium to phosphorous ratio (Ca/P) as helpful index to recognize primary hyperparathyroidism, but not primary hypoparathyroidism: a big-data approach

      ea0049gp51
  • Cardiovascular & Lipid Endocrinology
  • • Liraglutide prevents right ventricle hypertrophy by avoiding ACE1 & ACE2 reduction in an experimental model of idiopathic pulmonary fibrosis

      ea0049gp52
    • Clinical, laboratory and cardiac parameters in overt primary hypothyroidism versus overt central hypothyroidism

      ea0049gp53
    • Correlation between triglyceride glucose index (TyG) and coronary artery calcification in Korean adults

      ea0049gp54
    • Both oral and vaginal combined hormonal contraceptives induce unbeneficial metabolic effects in women with PCOS: a randomized study

      ea0049gp55
    • PCSK9 in relation to coronary damage severity in patients with cardiovascular disease

      ea0049gp56
    • Clinical significance and hormonal relationships of visceral adiposity index (VAI) in independently living old subjects

      ea0049gp57
    • Circulating levels of miR24-1 cluster microRNAs are increased in primary aldosteronism

      ea0049gp58
    • Body composition and testosterone determined VO2max in 780 young men - results from the Odense Androgen Study

      ea0049gp59
    • Probiotics and nutraceuticals as a new frontier in obesity prevention and management

      ea0049gp60
    • Constructing a long-acting leptin analogue

      ea0049gp61
  • Developmental & Protein Endocrinology
  • • Effects of prenatal dexamethasone on fetal rat ovary

      ea0049gp62
    • Does the loss of RAD52 in PC contribute to resistance to antiandrogen therapy?

      ea0049gp63
    • Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover

      ea0049gp64
    • 3-year safety and efficacy Update of the VERTICAL & VISTA trials of somavaratan (VRS-317), a long-acting rhGH, in children with Growth Hormone Deficiency (GHD)

      ea0049gp65
    • Achievement of a suitable basis of comparison in phase 2 and 3 clinical trials (VERTICAL/VISTA, and VELOCITY) comparing somavaratan vs daily rhGH for pediatric GH deficiency

      ea0049gp66
    • Karyotype and mid-childhood gonadotropin concentrations in prediction of spontaneous puberty in Turner syndrome patients

      ea0049gp67
    • Assessment of reports of behaviour by patients and their parents in paediatric Cushing disease

      ea0049gp68
    • 5[beta]-reductase (AKR1D1) is a potent regulator of carbohydrate and lipid metabolism and inflammation in human liver

      ea0049gp69
    • The adverse effects of prescribed glucocorticoids are worsened by co-administration of 5[alpha]-reductase inhibitors

      ea0049gp70
  • Diabetes & complications 1
  • • Carbohydrates metabolism and H. pylori: case-control study

      ea0049gp71
    • Specific plasma amino acids alternations associated with metabolic syndrome

      ea0049gp72
    • Permanent neonatal diabetes in a 24 year old Spanish patient

      ea0049gp73
    • Rescue study of trapped AVPR2 mutants with chemicals

      ea0049gp74
    • GLP-1 acutely regulates carbohydrate and lipid metabolic routes in the liver

      ea0049gp75
    • Increased risk of diabetes and hyperglycaemia associated with treatment with statins, beta-blockers and diuretics: the PPP-Botnia study

      ea0049gp76
    • Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection

      ea0049gp77
    • Contribution of genetic predisposition and lifestyle to gestational diabetes risk

      ea0049gp78
    • The rs2292239 polymorphism in the ERBB3 gene is associated with risk for type 1 diabetes mellitus

      ea0049gp79
    • Trace elements as an oxidative stress marker in women with gestational diabetes and their neonates

      ea0049gp80
    • Abstract unavailable

      ea0049gp81
    • Reduced level of soluble TLR2 in type 2 diabetes despite increased TLR2 monocyte expression

      ea0049gp82
  • Diabetes & complications 2
  • • Vitamin D metabolites and IL1[beta] RS16944 polymorphism in type 2 diabetes patients: evidence for functional interaction

      ea0049gp83
    • Antidiabetic medication use and the risk of fracture in type 2 diabetic patients: a nested case-control study

      ea0049gp84
    • Abstract unavailable

      ea0049gp85
    • Increased incidence of diabetes mellitus 30 years after the radiation impact in persons exposed to ionizing radiation during the Chernobyl NPP accident

      ea0049gp86
    • Baicalin lowers glucose intolerance by controlling pancreatic hormone in high fat-induced obese diabetic rats

      ea0049gp87
    • Effect of insulin on neurotrophins' levels in the muscular wall of mice intestine and colon

      ea0049gp88
    • Clinical assessment of trabecular bone microstructure in type 2 diabetes mellitus with Trabecular Bone Score (TBS)

      ea0049gp89
    • The G allele of the BDKRB1 rs12050217 polymorphism is associated with protection for diabetic retinopathy

      ea0049gp90
    • Dipeptidyl peptidase-4 inhibitor therapy and risk of diabetic retinopathy: a population based study

      ea0049gp91
    • Non-genetic rat model of nephropathy in type 2 diabetes with attenuated streptozotocin-induced tubular alteration

      ea0049gp92
  • Diabetes therapy & complications 1
  • • microRNA expression profile in plasma from patients with diabetic kidney disease

      ea0049gp93
    • The A allele of the -866G/A polymorphism in UCP2 gene decreases high glucose-induced UCP2 expression in HUVECs

      ea0049gp94
    • The relation between PON-1 activity and 25-OH hydroxyvitamin D3 levels and other biochemical parameters in diabetic patients with respect to obesity and diabetic complications

      ea0049gp95
    • High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with diabetic nephropathy and the role of netrin-1 levels

      ea0049gp96
    • Comparison of current perception threshold measured by Neurometer in patients with type 2 diabetes mellitus to a group of normal individuals

      ea0049gp97
    • Gestacional diabetes mellitus: the new screening criteria and its outcomes

      ea0049gp98
    • Higher levels of adiponectin might contribute to lower bone mass observed in patients with type 1 diabetes, through alterations in osteocalcin energy circuit signaling of bone cells.

      ea0049gp99
    • Type 1 diabetes and hearing loss: a meta-analysis

      ea0049gp100
    • Abstract unavailable

      ea0049gp101
    • Comparison of the effects of combinations of different antihypertensive therapies on microalbuminuria and renal functions in type 2 diabetic patients

      ea0049gp102
  • Diabetes therapy & complications 2
  • • Abstract unavailable

      ea0049gp103
    • Non-stimulated c-peptide is independently associated with requirement at 1 year for insulin therapy in patients with diabetes: a retrospective cohort study of 872 patients

      ea0049gp104
    • Ceramide synthase 6 inhibition as a novel therapeutic approach for obesity and type 2 diabetes

      ea0049gp105
    • Outcomes of integrating personal continuous glucose monitors with insulin pumps in a University Diabetes Unit

      ea0049gp106
    • Specific Oct1 gene variants are associated with changes in the risk of cardiovascular death in metformin users

      ea0049gp107
    • Liraglutide improves carotid intima-media thickness in pre-elderly and elderly patients with type-2 diabetes: an 18-month prospective, real life study

      ea0049gp108
    • Treatment of diabetic ketoacidosis at type 1 diabetes mellitus presentation: 13 year experience from a tertiary centre (2004-2016)

      ea0049gp109
    • The method of reporting hypoglycemia in Randomized Control Trials (RCTs): a systematic review on RCTs conducted for SGLT-2 inhibitors

      ea0049gp110
    • Hepatic effects of GLP-1 receptor agonist Liraglutide in patients with type 2 diabetes

      ea0049gp111
    • Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus

      ea0049gp112
  • Endocrine Nursing
  • • Impact of the socio-economic level on the management in type 2 diabetes

      ea0049gp113
    • Outcomes of a nurse-led thyroid clinic at a tertiary-care endocrine centre

      ea0049gp114
    • Education, patient empowerment and admission avoidance

      ea0049gp115
    • Recovery of the hypothalamus-pituitary-adrenal axis after transsphenoidal surgery for pituitary adenomas

      ea0049gp116
    • The Swedish Pituitary Register Nursing Group (SPRNG) Projects and Experiences

      ea0049gp117
  • Endocrine Tumours
  • • Luteinizing hormone receptor mediated GATA4 induction promotes adrenocortical tumorigenesis in gonadectomized mice

      ea0049gp118
    • Targeted molecular analysis in adrenocortical carcinomas: a way towards personalized medicine

      ea0049gp119
    • Evaluation of the occurrence of the manifestations of Carney complex in a french cohort of 70 patients during a three years standardized follow-up

      ea0049gp120
    • Immunity in adrenocortical carcinoma patients - interplay between anti-cancer immunity and steroid hormones

      ea0049gp121
    • The natural history of adrenal incidentaloma - results from the international prospective multi-centre EURINE-ACT study

      ea0049gp122
    • Outcome of patients with adrenocortical cancer after discontinuation of adjuvant mitotane therapy

      ea0049gp123
    • VHL Genotype and risk stratification of pancreatic neuroendocrine tumors in patients with von hippel-lindau disease

      ea0049gp124
    • GPER-stimulation increases proliferation in colorectal cancer via the Hippo signalling pathway

      ea0049gp125
    • Inhibition of hRAS and CDK4/6 leads to an antiproliferative activity, blocks cell cycle and induces cell death in anaplastic thyroid cancer cell lines

      ea0049gp126
    • Benign prostatic hyperplasia is associatied with liver inflammation: it's time for prevention?

      ea0049gp127
    • Peptides derived from the sst5TMD4 extracellular domain increase malignancy of endocrine-related cancer cells

      ea0049gp128
    • Androgen receptor activation inhibits endothelial cell proliferation through an extra-nuclear signaling pathway

      ea0049gp129
    • Long non-coding RNA expression profiles in human parathyroid tumors

      ea0049gp130
  • Female Reproduction
  • • Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial

      ea0049gp131
    • Testosterone administration decreases insulin sensitivity (IS) in adult female sheep born to testosterone treated mothers

      ea0049gp132
    • Influence of BMI on AMH levels in non-PCOS women

      ea0049gp133
    • Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis (EM)-associated pain: Phase 2 safety and efficacy 24-week results

      ea0049gp134
    • Brown adipose tissue thermogenesis in women with polycystic ovary syndrome

      ea0049gp135
    • Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin improved beta cell function and prevented a conversion rate to MTG and DM2 in metformin intolerant PCOS with high metabolic risk

      ea0049gp136
    • Genetic susceptibility for adrenal hyperandrogenism in polycystic ovary syndrome

      ea0049gp137
    • Turner's syndrome and abnormal liver chemistry: relationship with karyotype in a large dedicated clinic

      ea0049gp138
    • Sensitivity of hypothalamo-pituitary-adrenal axis in women with PCOS

      ea0049gp139
    • Nonalcoholic fatty liver disease liver fat score (NAFLD-LFS) could be used for the assessment of NAFLD in women with PCOS

      ea0049gp140
    • Effects of central sympathoinhibition with moxonidine on the elevated sympathetic nervous activity and downstream metabolic abnormalities observed in polycystic ovary syndrome

      ea0049gp141
    • Steroid receptors involvement in enamel hypomineralization resulting from exposure to low-dose DEHP and bisphenol A

      ea0049gp142
  • Male Reproduction and Endocrine Disruptors
  • • In vitro effects of Bisphenol A on two metabolic receptors signaling: MC4R and FFAR1

      ea0049gp143
    • Altered protein expression of cell cycle- and EMT-associated genes by bisphenol compounds in MCF-7 CV human breast cancer cells via estrogen receptor dependent pathway

      ea0049gp144
    • Reproductive toxicity of low dose nonylphenol in mice: a two-generation study

      ea0049gp145
    • Psychological rather than organic and/or relational components are involved in sexual dysfunction in Young/Middle aged human immunodeficiency virus (HIV)-Infected Men

      ea0049gp146
    • Effects of physical exercise or metformin on testosterone deficiency and erectile dysfunction associated to metabolic syndrome

      ea0049gp147
    • Impacts of a single ablative dose of radio iodine therapy for differentiated thyroid carcinoma on testicular function: results from the SAPIRA study

      ea0049gp148
    • Presentation, clinical features and long-term follow-up of Leydig cell tumours of the testis: 77 cases from a single center experience

      ea0049gp149
    • Semen quality in patients with adult-onset hypogonadotropic hypogonadism

      ea0049gp150
  • Neuroendocrinology & Growth Hormones
  • • Growth hormone-releasing hormone (GHRH) antagonists, MIA-602 and MIA-690, inhibit survival and proliferation of human pleural mesothelioma cells

      ea0049gp151
    • Somapacitan expected to provide IGF-I levels suitable for once-weekly dosing in children

      ea0049gp152
    • Evaluating CHARGE syndrome in CHD7-positive CHH patients: clinical implications

      ea0049gp153
    • The effect of chronic hypothalamic-pituitary-adrenal axis activation on hypothalamic glucagon-like peptide-1 action in an animal model of depression and in vitro studies

      ea0049gp154
    • A novel purified polyclonal antibody towards T-Pit is a reliable marker of corticotroph cell differentiation

      ea0049gp155
    • Liraglutide treatment prevented the increased expression of proinflammatory cytokines in the hippocampus of male pups in a perinatal stress model of food restriction

      ea0049gp156
    • Predictors of permanent, transient and three-phase postoperative diabetes insipidus

      ea0049gp157
    • The effect of chronic tianeptine administration on NLRP3 inflammasome pathway - study in an animal model of depression

      ea0049gp158
    • Pituitary androgen receptor signalling is a novel negative regulator of prolactin production

      ea0049gp159
    • Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson's syndrome

      ea0049gp160
  • Obesity
  • • The association between olfaction and taste functions with serum ghrelin and leptin levels in obese women

      ea0049gp161
    • Sarcopenic obesity and associated factors in older adults with diabetes: the 2009-2010 Korean National Health and Nutrition Examination Survey

      ea0049gp162
    • Resistance training reduces skeletal muscle inflammation even after 4-week detraining in obese rats

      ea0049gp163
    • miR-26b is decreased in obesity and is associated with insulin resistance and visfatin levels

      ea0049gp164
    • The effect of FTO polymorphism rs 9939609 on obesity and metabolic disturbances in Polish people from Lower Silesia

      ea0049gp165
    • Role of Elovl6 in brown and beige adipose tissue during [beta]3-adrenergic receptor activation

      ea0049gp166
    • A link between sex hormones, obesity and gut microbiota

      ea0049gp167
    • Effects of short sleep duration on energy metabolism and energy balance in subjects with overweight and obesity

      ea0049gp168
    • Blood mercury concentration in relation to overweight or obese among Korean children and adolescents: KNHANES 2009-2013

      ea0049gp169
    • Association of the FTO gene rs9939609 polymorphism with obesity in the Republic of Tatarstan

      ea0049gp170
    • Effect of bariatric surgery on sexual function and sex hormone levels in obese patients: a meta-analysis

      ea0049gp171
    • Lipolytic effects of endogenous 3-iodothyronamine (T1AM) and synthetic analog SG-2 in vivo and in cultured adipocytes

      ea0049gp172
  • Pituitary
  • • A comparison of single-dose effects of short acting somatostatin analogs: octreotide vs pasireotide in patients with active acromegaly after surgical debulking

      ea0049gp173
    • Efficacy and safety of switching to pasireotide LAR alone or in combination with pegvisomant in acromegaly patients controlled with combination treatment of first-generation somatostatin analogues and weekly pegvisomant (PAPE study): a prospective open-label 48 week study, preliminary results 24 weeks

      ea0049gp174
    • Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients

      ea0049gp175
    • Minimally Invasive Diagnosis and Direct Transnasal Surgery: a single centre series of 100 children with Cushing's Disease with long term follow-up

      ea0049gp176
    • Octreotide subcutaneous (s.c.) depot, a novel ready-to-use formulation, provides higher exposure and maintains response in patients with acromegaly and functioning neuroendocrine tumours (NETs) previously treated with long-acting octreotide: Results from a phase 2, open-label, multicentre, randomized study

      ea0049gp177
    • Sleep patterns in patients with non-functional GHRH receptor

      ea0049gp178
    • Correction of sustained hyponatremia secondary to SIAD by the use of chronic tolvaptan therapy is associated with a reduction in Emergency Room visits, hospital admissions and days of hospitalization over a 3-year period

      ea0049gp179
    • Outcome of non-functioning pituitary adenomas that regrow after primary treatment: a study from two large specialist UK centers

      ea0049gp180
    • Targeting either GH or IGF-I levels during somatostatin analogue treatment in patients with acromegaly: A randomized, investigator-initiated multicenter study

      ea0049gp181
    • Brain white matter damage and volumes of hippocampus and hypothalamus correlates to cognitive function in craniopharyngioma

      ea0049gp182
    • Copeptin - a sensitive marker of an altered CRH-axis in pituitary disease

      ea0049gp183
    • Hormonal and metabolic effects of long-term cabergoline withdrawal in patients with hyperprolactinemia

      ea0049gp184
  • Pituitary & endocrine Tumours
  • • Localization of benign insulinomas using glucagon-like peptide-1 receptor (GLP1-R) SPECT/CT and PET/CT and MRI in a prospective clinical study

      ea0049gp185
    • 24 hour urinary 5-hydroxyindoleacetic acid (5-HIAA) doubling-time (DT) is associated with disease-specific mortality (DSM) and progression-free survival (PFS) in patients with neuroendocrine tumors (NETs)

      ea0049gp186
    • Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing's disease (CAPACITY)

      ea0049gp187
    • Vertebral fractures are prevalent among patients with acromegaly in spite of normal bone mineral density reflecting overall duration of disease regardless of biochemical control or cure

      ea0049gp188
    • Evaluation of pituitary toxicity after radiotherapy for cerebral chondrosarcomas in adult patients

      ea0049gp189
    • Safety of long-term growth hormone (GH) treatment in adults with GH deficiency (GHD): an analysis from the NordiNet® International Outcome Study

      ea0049gp190
    • GH and IGF-1 levels at 12 weeks predict long-term responses to lanreotide Autogel in treatment-naive acromegalic patients: post-hoc analyses from the PRIMARYS study

      ea0049gp191
    • Long-term treatment with pegvisomant (Somavert®): Observations from 2090 acromegaly patients followed in ACROSTUDY

      ea0049gp192
    • Amenorrhea without vasomotor symptoms in women over 40: A sign of pathological hyperprolactinemia?

      ea0049gp193
    • Serotonin, ATRX and DAXX as differential diagnostic markers of neuroendocrine tumours (NETs) in the sellar region. An immunohistochemical study in a large series of pituitary adenomas and in a non-pituitary NET

      ea0049gp194
    • Long-term follow-up of a family with a large AIP gene deletion: variable phenotypes and challenges in the management

      ea0049gp195
    • Diagnosis of acromegaly: Sex and BMI are the major determinants of growth hormone suppression during oral glucose tolerance test (OGTT)

      ea0049gp196
  • Thyroid 1
  • • Cognitive functions in primary hypothyroidism on selenium supplementation

      ea0049gp197
    • Which is the best tool to use when initiating the differential diagnosis of a thyrotoxic patient? A challenge to current guideline recommendations

      ea0049gp198
    • Cardiovascular risk factors in patients with autoimmune thyroiditis

      ea0049gp199
    • Evaluation of the effectiveness of personalized radioiodine treatment in Graves' disease

      ea0049gp200
    • Abstract unavailable

      ea0049gp201
    • Citrus flavanones naringenin and hesperetin induced mild functional alteration in thyroids of old-aged Wistar rats

      ea0049gp202
    • The oxford multidisciplinary thyroid eye disease (TED) clinic; can short waiting times and use of steroid sparing agents (SSA) reduce total steroid dose and requirement for surgery/radiotherapy?

      ea0049gp203
    • 24-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules

      ea0049gp204
    • Association of vitamin D levels with thyroid function and autoimmunity

      ea0049gp205
  • Thyroid 2
  • • Early use of steroid-sparing agents in treatment of moderate-to-severely active thyroid eye disease

      ea0049gp206
    • Prediction of response to methimazole based on clinical symptoms in new onset graves' patients, using neural networks

      ea0049gp207
    • Serum Interleukin-37 (IL-37) levels were increased and correlated with oxidative stress parameters in Hashimoto's Thyroiditis (HT) patients

      ea0049gp208
    • The increased immunohistochemical expression of IL-23 in Hashimoto's thyroiditis but not in Graves' disease patients

      ea0049gp209
    • Laser ablation of benign thyroid nodules without anesthesia: clinical tolerance, hazards and complications

      ea0049gp210
    • Orbital ectopic thyroid mistaken for mestastases

      ea0049gp211
    • Association of the Period3 clock gene polymorphism with autoimmune thyroid diseases

      ea0049gp212
    • IgG4-related fibrous variant of Hashimoto thyroiditis in a non-Asian woman

      ea0049gp213
    • Thyroid hormones deficiencies and poor outcome in chronic heart failure outpatients

      ea0049gp214
    • Hypothyroidism and heart failure outcome: a study with a long-term follow-up

      ea0049gp215
    • The correction of TSH with thyroid replacement therapy is associated with a better outcome in chronic heart failure patients

      ea0049gp216
  • Thyroid 3
  • • Thyroid function in heart failure with preserved ejection fraction (HFpEF) - evaluation of serum and myocardial thyroid hormones in an animal model of HFpEF

      ea0049gp217
    • STAT6 deficiency ameliorates Graves' disease severity by suppressing thyroid epithelial cell hyperplasia

      ea0049gp218
    • Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy in patients with differentiated thyroid cancer

      ea0049gp219
    • Analysis of a large cohort of subjects with thyroid hemiagenesis (THA) reveals random seasonality in the dates of birth

      ea0049gp220
    • Thyroid hormone T3 protects mice from fasting induced skeletal muscle atrophy by counteracting autophagy

      ea0049gp221
    • Will it be useful to measure PTH at 4 hours post thyroidectomy to decide for calcium replacement? 1st result of a prospective study

      ea0049gp222
    • Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG)

      ea0049gp223
    • Impact of chronic high fat diet consumption on the expression of organic nutrients carriers in the small intestine of mice: role of thyroid hormones in these processes

      ea0049gp224
  • Thyroid Cancer
  • • Prognostic factors for intrathyroidal papillary carcinomas - a multivariate analysis

      ea0049gp225
    • Malignancy Rate in Thyroid Nodules: Cytology versus Histology in challenging categories

      ea0049gp226
    • Fine needle aspiration biopsy in pediatric patients with thyroid nodules

      ea0049gp227
    • Differentiated thyroid cancer - comparison between patients with and without remission

      ea0049gp228
    • Trends in papillary microcarcinoma prevalence in North of Portugal

      ea0049gp229
    • Radioiodine (RAI) refractory differentiated thyroid cancer (DTC): outcome and prognostic factors for DISEASE progression

      ea0049gp230
    • Management and outcome of bone metastasis from differentiated thyroid carcinoma in the real life: the M.OS.CA.TI. study

      ea0049gp231
    • Germ-line mutations in RET-790 and RET-791 codons (exon 13) among subjects with sporadic medullary thyroid cancer

      ea0049gp232
    • Comparison of clinicopathological features in patients with familial and sporadic papillary thyroid cancer

      ea0049gp233
    • Lobectomy as a treatment option for well differentiated thyroid cancer (WDTC) between 1-4 cm: which results should we expect?

      ea0049gp234
    • Clinical Utility of response to therapy in combination with BRAF in risk assessment of thyroid cancer

      ea0049gp235
  • Thyroid Cancer & Thyroid Case Reports
  • • A rare case of medullary thyroid cancer, mesothelioma and meningioma, due to APC and RASAL1 mutations

      ea0049gp236
    • Thyrotoxic Periodic Paralysis due to Graves' disease: a mandatory differential diagnosis in Asian patients presenting with paralysis and hypokalemia

      ea0049gp237
    • A fatal case of fetal goiter: autoimmunity is the key

      ea0049gp238
    • Renal cell carcinoma metastasis to thyroid tumor: a case report

      ea0049gp239
    • Giant goiter with intrathyroid arteriovenous fistula as a cause of severe pulmonary hypertension

      ea0049gp240
    • Thyroid-related adverse events in patients treated with Nivolumab

      ea0049gp241
    • False negative fine needle aspiration thyroid cytology: an institutional experience

      ea0049gp242
    • Risk factors associated with malignancy in thyroid nodules classified as Bethesda category IV (follicular neoplasm/suspicious for follicular neoplasm)

      ea0049gp243
    • Expressions of miRNAs and BRAFV600E mutation detection in papillary thyroid carcinoma

      ea0049gp244
    • A statistical, in silico model predicts polygenic thyroid cancer risk

      ea0049gp245
• Eposter Presentations: Adrenal and Neuroendocrine Tumours
• • Adrenal cortex (to include Cushing's)
  • • Confirmatory tests for diagnosis of primary aldosteronism among Chinese hypertensives

      ea0049ep1
    • The correlation of salivary cortisol values with serum cortisol values

      ea0049ep2
    • Adrenocortical virilizing tumor in an adult woman in remission after surgical therapy performed more than 12 years ago

      ea0049ep3
    • Investigation of atrophic adrenal glands in Cushing's syndrome model rats induced by the administration of dexamethasone

      ea0049ep4
    • Long-term assessment of AddiQoL and patient diaries may identify Addison patients at high risk for adrenal crises

      ea0049ep5
    • Impact of Cortrosyn treatment on weight and adrenal structure in the wistar rat

      ea0049ep6
    • Molecular variability determines subtle adrenal biosynthetic defect in non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0049ep7
    • Corticoids-therapy related complications in patients with primary adrenal insufficiency

      ea0049ep8
    • Severe hypertriglyceridemia in relation to toxic levels of mitotane in a patient with stage IV adrenocortical carcinoma (ACC)

      ea0049ep9
    • Addison's disease presenting as severe hypoglycaemia and cachexia

      ea0049ep10
    • Posterior reversible encephalopathy syndrome (PRES) in a patient with primary aldosteronism

      ea0049ep11
    • Evaluation of cardiovascular risk in patients with adrenal incidentaloma

      ea0049ep12
    • Hair cortisol in patients with primary aldosteronism

      ea0049ep13
    • Salivary steroid levels during diagnostic tests for adrenal insufficiency

      ea0049ep14
    • Assessment of quality of life of patients with Cushing's syndrome depending on the disease course

      ea0049ep15
    • Paraneoplastic Cushing's syndrome and nephrotic syndrome in a patient with bronchial carcinoid

      ea0049ep16
    • Frequancy of diabetes and prediabetes in patients with adrenal incidentaloma without hormonal activity

      ea0049ep17
    • To big to work! Lymphoma presenting with primary adrenal insufficiency

      ea0049ep18
    • Specificity of the posture test for subtyping of primary aldosteronism, a 10 year nationwide summary in Iceland

      ea0049ep19
    • Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells

      ea0049ep20
    • Primary Aldosteronism in Iceland, nationwide results from 2012-2016

      ea0049ep21
    • Cardiovascular risk factors do not play a role in the risk factor profile of adrenal crisis

      ea0049ep22
    • Bilateral adrenal incidentaloma: a diagnostical and therapeutical challenge

      ea0049ep23
    • Are we missing patients with primary aldosteronism (PA) if we require both elevated aldosterone: renin ratio (ARR) and elevated aldosterone levels?

      ea0049ep24
    • Severe hypoglycaemic ketoacidosis in a patient with adrenal crisis

      ea0049ep25
    • Assessment of the hypothalamic pituitary adrenal axis in patients receiving adjuvant mitotane treatment after radical resection of adrenocortical carcinoma

      ea0049ep26
    • Extra-gastrointestinal stromal tumor in the retroperitomeum which had difficulty in differential diagnosis with adrenal cancer

      ea0049ep27
    • Perceptions of medical practitioners' management of addison's disease across Africa: an on-line survey

      ea0049ep28
    • Improved metabolic outcomes for patients with subclinical Cushing's syndrome treated with surgery: Ten year experience in a tertiary centre

      ea0049ep29
    • Severe hypoaldosteronism after unilateral adrenalectomy for primary hyperaldosteronism

      ea0049ep30
    • The role of CYP11B2 polymorphism in the pathogenesis of hypertension in patients with adrenal incidentaloma

      ea0049ep31
    • Primary aldosteronism: more common than once thought: Two clinical cases

      ea0049ep32
    • Rapid reduction in left ventricular mass in primary aldosteronism after treatment; a prospective cardiac MRI study

      ea0049ep33
    • The treatment with dual release hydrocortisone in patients with adrenal insufficiency: correlation between change of the evening cortisol exposure time profile and change in metabolic profile, depression status and quality of life

      ea0049ep34
    • Treatment of adrenal insufficiency with hydrocortisone dual-release formulation: glycometabolic profile and health-related quality of life

      ea0049ep35
    • Transformation from Addison's disease to adrenocortical carcinoma presented as Cushing's syndrome with androgenisation

      ea0049ep36
    • Visinin-Like Protein-1 in the regulation of aldosterone biosynthesis

      ea0049ep37
    • Metabolic syndrome is common among patients with adrenal incidentalomas, but not associated with functional adrenal status

      ea0049ep38
    • The clinical course of patients with adrenal incidentaloma: Başkent University experience

      ea0049ep39
    • Predictive baseline morning P-cortisol levels for the response to a Synacthen test in prednisolone treated patients

      ea0049ep40
    • Silent pheochromocitoma - a rare case of adrenal incidentaloma

      ea0049ep41
    • LH and adrenal tumor size correlate with insulin resistance in menopausal patients with adrenal incidentalomas and (possible) autonomous cortisol secretion

      ea0049ep42
    • A case of recurrent Cushing's disease after total bilateral adrenalectomy

      ea0049ep43
    • Late-night salivary cortisol: cut-off definition and diagnostic value in Cushing's syndrome

      ea0049ep44
    • Adrenal involvement in MEN1 families

      ea0049ep45
    • Differential effects of aldosterone excess on potassium homeostasis and blood pressure in Asian subjects

      ea0049ep46
    • Effect of adrenal mass lateralization on diagnostic tests in patients with Cushing

      ea0049ep47
    • Late night salivary cortisol measurement may help in excluding Cushing's syndrome in patients with chronic kidney disease

      ea0049ep48
    • The short Synacthen test revisited - reevaluation of the normal reference range using LCMSMS

      ea0049ep49
    • Cushing's syndrome in pregnant woman

      ea0049ep50
    • Education sessions in patients with adrenal insufficiency

      ea0049ep51
    • Characteristics of aldosterone-producing adenomas: a tissue microarray study

      ea0049ep52
    • Adrenal cushing's syndrome surprisingly unveiling breast cancer

      ea0049ep53
    • Giant adrenal tumor in a patient admitted for fever

      ea0049ep54
    • The relative risk of developing Addison's disease among patients with type 1 diabetes mellitus: a nationwide, matched, observational cohort study

      ea0049ep55
    • The frequency of incidental liver and renal masses in patients with adrenal incidentalomas

      ea0049ep56
    • Primary adrenal insufficiency: a Portuguese multicentre study by the adrenal tumour study group

      ea0049ep57
    • Adrenal incidentaloma: a challenging dilemma!

      ea0049ep58
    • Assay of steroids with Liquid chromatography tandem mass spectrometry is superior to immunoassays in monitoring patients with 21-hydroxylase deficiency

      ea0049ep59
    • Treatment of patients with primary and secondary adrenal insufficiency with hydrocortisone modified-release (Plenadren®)

      ea0049ep60
    • Autoimmune Addison disease - data from long-term follow-up of patients from a tertiary hospital's Endocrinology Department

      ea0049ep61
    • Effect of GH treatment on coagulation and fibrinolysis parameters in prepubertal children with growth hormone deficiency

      ea0049ep62
    • Treatment with modified-release hydrocortisone for 6 months: A clinical audit in 15 patients with adrenal insufficiency

      ea0049ep63
    • Cushing's Syndrome During Pregnancy mimicking preeclampsia - case report

      ea0049ep64
    • Potentially aggressive adrenal oncocytoma during pregnancy: about one case

      ea0049ep65
    • Primary hyperparathyroidism associated with Cushing syndrome and primary hyperaldosteronism

      ea0049ep66
    • Comparison of biochemical and hormonal parameters in patients with primary adrenal insufficiency of autoimmune and no-autoimmune cause

      ea0049ep67
    • The role of dehydroepiandrosterone sulphate (DHEAS) in the evaluation of autonomous cortisol secretion in adrenal incidentalomas

      ea0049ep68
    • Adrenocortical carcinoma in pregnancy

      ea0049ep69
    • Abnormal aldosterone/renin ratio is common in patients of African compared to European origin, is associated with hypokalaemia, and left ventricular hypertrophy, but is rarely associated with abnormal adrenal imaging characteristics

      ea0049ep70
    • Neutrophil-lymphocyte and platelet-lymphocyte ratios as biomarkers in distinguishing adrenocortical adenomas and carcinomas

      ea0049ep71
    • Adrenal involvement of Non-Hodgkin's lymphoma: a case report

      ea0049ep72
    • Challenges in differential diagnosis of adrenal incidentaloma or clinical case of multiple myeloma

      ea0049ep73
    • Iatrogenic Cushing syndrome and suprarenal secondary insufficiency due to interaction between fluticasone and ritonavir

      ea0049ep74
    • Body composition in women with Cushing's syndrome of different etiology

      ea0049ep75
    • Clinical course of patients with adrenal incidentaloma: retrospective analysis of a single center

      ea0049ep76
    • Malignant androgen-secreting adrenocortical carcinoma with adrenal insufficiency: a case report

      ea0049ep77
    • Hyperaldosteronism screening in Hypertensiologists experience - epidemiological review of over 800 cases

      ea0049ep78
    • Clinical, laboratorial and densitometric evaluation of adult women with congenital adrenal hyperplasia

      ea0049ep79
    • The effect of subclinical hypercortisolism on bone mineral density in female patients with adrenal incidentalomas

      ea0049ep80
    • Long term follow up of patients with adrenal incidentaloma and 'autonomous cortisol secretion'

      ea0049ep81
    • Adrenocortical carcinoma - casuistic analysis

      ea0049ep82
    • A near miss on blaming the heart: a rare case of Adrenocortical carcinoma with thrombus extension into right atrium and Cushing syndrome

      ea0049ep83
    • Congenital Adrenal Hyperplasia due to 11[beta]-Hydroxilase Deficiency: clinical and molecular studies of two novel families with variable phenotypes

      ea0049ep84
    • 'Record-breaking hyponatraemia' with Addison's disease

      ea0049ep85
    • 24 hour ambulatory blood pressure levels according to adrenal adenoma size

      ea0049ep86
  • Adrenal medulla
  • • Coexisting Graves's disease and pheochromocytoma

      ea0049ep87
    • Pheochromocytoma in neurofibromatosis type 1

      ea0049ep88
    • Should all patients with Neurofibromatosis type 1 undergo biochemical screening for Pheocromocytoma?

      ea0049ep89
    • Pheochromocytoma in pregnancy

      ea0049ep90
    • The role of p27 in pheochromocytoma development

      ea0049ep91
    • Role of microenvironment on metabolic control of murine pheochromocytoma SDHB silenced cells

      ea0049ep92
    • Role of microenvironment on proliferation and migration of an SDHB silenced murine Pheochromocytoma cell line

      ea0049ep93
    • Pheochromocytoma: a clinical and pathological study

      ea0049ep94
    • Biochemical testing for pheochromocytoma

      ea0049ep95
    • Paraganglioma and Fallot Tetralogy: case report

      ea0049ep96
    • Retrospective audit at a UK teaching hospital of phaeochromocytomas and paragangliomas against the 2016 guidelines

      ea0049ep97
    • Pheochromocytoma - surgical outcomes

      ea0049ep98
    • Role of urinary fractionated metanephrines and catecholaminas in the diagnosis of pheochromocytoma/paraganglioma

      ea0049ep99
    • Lung adenocarcinoma in a 34-year-old female SDHB asynptomatic mutation carrier - case report

      ea0049ep100
    • Pheochromositoma in childhood

      ea0049ep101
    • A case of silent pheochromocytoma presenting with clinical and radiological findings suggesting metastatic adrenal lesion

      ea0049ep102
    • The storm before the calm: a phaeochromocytoma

      ea0049ep103
    • Improvement of insulin secretion and oral glucose tolerance after pheochromocytoma removal: a case report

      ea0049ep104
    • Ephedrine/caffeine toxicity masquerading as phaeochromocytoma in a vigorexic male with paroxysmal hypertension and headache

      ea0049ep105
    • Loss diagnosis of pheochromocytoma in the initial evaluation

      ea0049ep106
    • Unexplained resistant hypertension in a young male with recurrent transient ischemic attacks, resembling endocrine hypertension

      ea0049ep107
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Stress cardiomyopathy in pheochromocytoma

      ea0049ep108
  • Clinical case reports - Pituitary/Adrenal
  • • Prolonged zona glomerulosa insuffiency with hyperkalemia in primary hyperaldosteronism after adrenalectomy

      ea0049ep109
    • Mature ganglioneuroma of the adrenal gland

      ea0049ep110
    • Primary adrenal insufficiency and pregnancy - a case report

      ea0049ep111
    • Paraganglioma (PG) and cyanotic congenital heart disease (CCHD): the role of tisular hypoxia

      ea0049ep112
    • Von Hippel Lindau disease in two Turkish families with different mutations

      ea0049ep113
    • Large adrenal adenoma presenting as a clinically inapparent Cushing syndrome, a trap diagnosis

      ea0049ep114
    • NK/T lymphoma adrenal presenting as adrenal insufficiency and cranial nerves neuropathies-a case report

      ea0049ep115
    • Primary hyperparathyroidism and primary hyperaldosteronism - cause or coincidence in arterial hypertension - case report

      ea0049ep116
    • Endocrine masses displayed as incidentalomas in patients with unilateral nephrectomy

      ea0049ep117
    • Case with metastatic lung cancer who developed adrenal insufficiency

      ea0049ep118
    • Adrenal haemorrhage: from Urology to Endocrinology

      ea0049ep119
    • Hemangioma a rare adrenal tumors: report of two cases

      ea0049ep120
    • A rare case: adrenal lymphangioma

      ea0049ep121
    • A rare case of a patient with MEN 4 phenotype and associated pheochromocytoma

      ea0049ep122
    • The difficulty in predicting aggressive tumour behaviour of phaeochromocytomas

      ea0049ep123
    • An unusual cause of unilateral adrenal haemorrhage

      ea0049ep124
    • Incidentaloma as a first manifestation of lymphoma

      ea0049ep125
    • Clinical case of aldosterone-producing adrenocortical carcinoma

      ea0049ep126
    • The case of adrenal incidentaloma due to unrecognized nonclassic congenital adrenal hyperplasia

      ea0049ep127
    • DOC secreting adrenal adenoma, a rare cause of hypertension

      ea0049ep128
    • Aldosterone-producing adrenocortical carcinoma and alteration of secretion pattern on recurrence: a case report

      ea0049ep129
    • Congenital adrenal hyperplasia: hazards of non-compliance with treatment!

      ea0049ep130
    • Adrenal insufficiency due to both hemorrhage and thrombosis related with primary antiphospholipid syndrome

      ea0049ep131
    • In spite of long-term symptoms, a pheochromocytoma diagnosed in pregnancy results in fetal loss despite proper approach

      ea0049ep132
    • POEMS: a rare cause of adrenal insufficiency in a young male

      ea0049ep133
    • Recurrent phaeochromocytoma - Iatrogenic

      ea0049ep134
    • An association of adrenal ganglioneuroma, Addison's disease and Mediterranean fever: a case report

      ea0049ep135
    • Adrenal carcinoma after ovariectomy. Report of a case

      ea0049ep136
    • ACTH-independent Cushing syndrome with concomitant parathyroid carcinoma

      ea0049ep137
    • Incidental adrenal cyst: a case report

      ea0049ep138
    • Gynecomastia in men: A rare case of adrenal feminizing tumors

      ea0049ep139
    • Virilization - a non-negligible manifestation of an adrenal tumor

      ea0049ep140
  • Clinical case reports - Thyroid/Others
  • • The ovarian origin of hiperandrogenism in the postmenopausal woman with the adrenal adenoma - a case report

      ea0049ep141
    • Secondary autonomic neuropathy in patient with polyglandular autoimmune syndrome III and type 1 gastric neuroendocrine tumor: a case report

      ea0049ep142
    • MEN 1 Syndrome- a case with recurrence of neuroendocrine tumor and hyperparathyroidism after 9 years of follow up

      ea0049ep143
    • Insulinoma- from diagnosis to full recovery. Case study

      ea0049ep144
    • Insulinoma masquerading as neurologic disease

      ea0049ep145
  • Endocrine tumours and neoplasia
  • • Glucose metabolism abnormalities and insulin resistance are frequent in well diferentiated digestive NETs

      ea0049ep146
    • Clinical and hormonal characteristics of adrenal incidentalomas

      ea0049ep147
    • Pituitary insufficiency, the beginning of a diagnostic journey

      ea0049ep148
    • Thyroid carcinoma in multiple endocrine neoplasia type 1

      ea0049ep149
    • Small pancreatic neuroendocrine incidentalomas: an observational prospective study

      ea0049ep150
    • Potential inhibitory effect of progesterone on breast cancer metastasis via the regulation on protein expression of apoptosis- and EMT-related genes

      ea0049ep151
    • Incidental paraganglioma, diagnosis and follow-up - case report

      ea0049ep152
    • Primary hepatic neuroendocrine tumor with multiple liver metastases treated with somatostatin analogues: case report

      ea0049ep153
    • Development of an everolimus-resistant BON1 cell line with altered cell cycle and c-Met activity

      ea0049ep154
    • False positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine Positron Emission Tomography (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors

      ea0049ep155
    • Imaging follow-up of non-functioning adrenal masses at Vilnius University Hospital Santariskiu Klinikos: 2010-2016

      ea0049ep156
    • Medullary thyroid carcinoma and pheochromocytoma in multiple endocrine neoplasia type 2A - a reversed order diagnosis

      ea0049ep157
    • Bilateral pheochromocytomas, asyptomatic medullary thyroid carcinoma associated with left side thyroid hemiagenesis in a patient with MEN2A: diagnostic correlations

      ea0049ep158
    • Follow-up of adrenal incidentalomas after the initial approach

      ea0049ep159
    • A case of silent pancreatic neuroendocrine tumour of carcinoid variety masquerading as an insulinoma

      ea0049ep160
    • CYP2W1*6 polymorphism as a potential predictive marker of sensitivity to mitotane treatment in adrenocortical carcinoma.

      ea0049ep161
    • Abstract unavailable

      ea0049ep162
    • Ectopic ACTH-syndrome - 31 consecutive patients from the Helsinki University Hospital

      ea0049ep163
    • Ectopic Cushing's syndrome caused by a pulmonary adrenocorticotropic hormone secreting tumour: a case report

      ea0049ep164
    • Could alcohol ablation become the standard of care for benign insulinomas?

      ea0049ep165
    • Clinical characteristics and survival of patients with paraganglioma: a single center experience

      ea0049ep166
    • Corticotroph deficiency in patients with insulinoma

      ea0049ep167
    • Hyperinsulinemic hypoglycemia in a 71-year-old patient with a suspected case of [beta]-cells hyperplasia of pancreatic body and tail- case report

      ea0049ep168
    • Respiratory symtoms lead to a diagnosis of pheochromocytoma: An unusual presentation

      ea0049ep169
    • A rare cause of secondary endocrine hypertension in a young woman with hypokaliemia and recurrent transient ischemic attacks

      ea0049ep170
    • Atypical symptoms of hypoglycemia, hiding a diagnosis of insulinoma: a case report

      ea0049ep171
    • A nomogram consisted of routine biochemical tests may increase the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine tumors

      ea0049ep172
    • Concentration of dehydroepiandrosterone sulphate in 109 males and 54 females with adrenal tumors

      ea0049ep173
    • Jejunum/ ileum Neuroendocrine Tumours: results of a multicentric retrospective study

      ea0049ep174
    • Follow-up in neuroendocrine tumors: is chromogranin A the confounder?

      ea0049ep175
    • Large intestinal metaplasia is a precancerous lesion present in patients with gastric neuroendocrine neoplasms type 1

      ea0049ep176
    • Pancreatic neuroendocrine tumors (PNETs) in patients with MEN1 syndrome

      ea0049ep177
    • Dysregulation of the components of the splicing machinery in neuroendocrine tumors and its association with malignancy and aggressiveness

      ea0049ep178
    • Serum succinate: investigation of its putative role as a new biomarker in malignant SDH-x mutated pheochromocytoma-paraganglioma patients?

      ea0049ep179
    • Survival analysis of patients with gastroenteropancreatic neuroendocrine tumors

      ea0049ep180
    • Insulinoma - clinical features and outcome of patients diagnosed at a central hospital

      ea0049ep181
    • Effects of ketoconazole on ACTH-producing and non ACTH-producing neuroendocrine tumor cells

      ea0049ep182
    • Treatment with (177Lu)-DOTATATE in patients with advanced metastatic somatostatin receptor-positive tumors

      ea0049ep183
    • Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) followed in the endocrinology and nutrition service's monographic outpatient clinics of neuroendocrine tumors in hospital clinico san carlos (HCSC). Description of its characteristics and evolution

      ea0049ep184
    • Descriptive and survival study of 142 cases of gastroenteropancreatic neuroendocrine tumor (GEP-NETs) diagnosed at the Hospital Clinico San Carlos (HCSC)

      ea0049ep185
    • Nonfunctional adrenal incidentaloma affects central blood pressures and arterial stiffness parameters

      ea0049ep186
    • Landscape of sporadic adrenal tumours from surgical unit - histopathological audit of 101 cases from a single centre in Poland

      ea0049ep187
    • An elevated chromogranin A: is it always a tumor progression?-case report

      ea0049ep188
    • An unknown giant neuroendocrine tumor

      ea0049ep189
    • A challenging case of metastatic paraganglioma and metastatic melanoma and prolactinoma

      ea0049ep190
    • Biology and differential diagnosis of calcitonin secreting neuroendocrine tumors

      ea0049ep191
    • Cancerous neuroendocrine vs endocrine tumours: broad commonalities and differences

      ea0049ep192
    • Short-term contralateral recurrence of a Litynski-Conn adenoma

      ea0049ep193
    • Acinic cell adenocarcinoma of the parotid gland associated with paraneoplastic Cushing's syndrome - a rare clinical case

      ea0049ep194
    • Malignant pheochromocytoma - a challenging diagnosis with nonconsensual management

      ea0049ep195
  • Neuroendocrinology
  • • Identification of molecular targets of Sunitinib in pancreatic neuroendocrine tumours

      ea0049ep196
    • Study of different in vitro systems for the evalutation of Sunitinib effects in pancreatic neuroendocrine tumour cells

      ea0049ep197
    • Von Hippel-Lindau syndrome: in vivo portrait with 68Ga-DOTANOC PET-CT

      ea0049ep198
    • Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinico-pathological characteristics and disease outcome of 110 patients treated at single referral medical center

      ea0049ep199
    • Insulinoma: diagnostic features and treatment management

      ea0049ep200
    • A rare case: non-islet cell tumor hypoglycemia with adrenal insufficiency

      ea0049ep201
    • Late manifestation of a mixed adenoneuroendocrine carcinoma of the cecum

      ea0049ep202
    • Quality of life in patients with neuroendocrine tumors treated with 177Lu-[DOTA0,Tyr3]-octreotate: a Single Tertiary Care Portuguese Center Experience

      ea0049ep203
    • Triple tumors in a patient with insulinoma

      ea0049ep204
  • Paediatric endocrinology
  • • An analysis of R356W and Q318X mutations and 8 bp deletion in 21-hydroxylase gene CYP21A2 in causing pseudo-precocious puberty in patients with congenital adrenal hyperplasia in Pakistani children

      ea0049ep205
    • Congenital adrenal hyperplasia: impact of therapy on growth and sexual maturation - a 5-year retrospective study of a Tertiary Pediatric Endocrinology Center

      ea0049ep206
  • Pituitary - Clinical
  • • The risk of hypotension, evaluated by ambulatory blood pressure monitoring, during fasting and outside fasting in patients with adrenal insufficiency

      ea0049ep207
  • Steroid metabolism + action
  • • Steroid metabolome changes in the 1 mg dexamethasone suppression test

      ea0049ep208
  • Thyroid cancer
  • • Clinical relevance of RET proto-oncogene variants L769L and S836S (exon 11, 13, 14, and 15) in patients with sporadic medullary thyroid carcinoma

      ea0049ep209
• Eposter Presentations: Calcium and Bone
• • Bone & Osteoporosis
  • • Abstract unavailable

      ea0049ep210
    • Bisphosphonate related osteonecrosis of the jaw: risk factors: a case report

      ea0049ep211
    • Salmon calcitonin affects thyroid endocrine cells and trabecular bone in a rat model of male osteoporosis

      ea0049ep212
    • Primary hyperparathyroidism: hormonal profile and risk of complications

      ea0049ep213
    • Efficacy and safety of bisphosphonate discontinuation in postmenopausal osteoporosis: a systematic review

      ea0049ep214
    • Osteopetrosis vs Osteogenesis Imperfecta-is that so hard to distinquish? Case report

      ea0049ep215
    • Osteonecrosis of the jaw and bilateral atypical femoral fracture both occurring during treatment of osteoporosis

      ea0049ep216
    • Clinical manifestations and treatment approach in osteogenesis imperfecta

      ea0049ep217
    • Special features of body composition and bone mineral metabolism in children with primary nephrotic syndrome

      ea0049ep218
    • Bone densitometry of type 2 diabetics (about 290 patients)

      ea0049ep219
    • Effects of acromegaly on bone tissue mRNA levels relevant to bone metabolism

      ea0049ep220
    • Osteoporosis and fractures in the real world setting

      ea0049ep221
    • Is osteoporosis a curable disease?

      ea0049ep222
    • Fractures at post-partum and lactation: common presentation of different clinical entities

      ea0049ep223
    • A multidisciplinary clinic for bone metabolism diseases; descriptive analysis of our experience in quiron salud malaga hospital

      ea0049ep224
    • Spontaneous recovery of BMD after surgical cure of Cushing's syndrome due to an adrenocortical adenoma: a 9-years follow-up

      ea0049ep225
    • Cinacalcet for control of primary hyperparathyroidism: a single centre experience

      ea0049ep226
    • Bone remodeling markers predict bone loss in premenopausal women

      ea0049ep227
    • Bone mineral density in hospital male physicians over the age of 65

      ea0049ep228
    • Association between bone mineral density and muscle strength in patients with Turner syndrome, after consideration of selected hormonal and metabolic parameters

      ea0049ep229
    • Volumes of visceral adipose tissue, gynoid and android fat as predictors of reduced bone mineral density in women with menstrual disorders

      ea0049ep230
    • Effect of chronic atrophic gastritis on bone mineral density of Korean women

      ea0049ep231
    • May serotonin metabolism polymorphisms 5HTTVNTR and 5HT_2A have a clinical impact in osteoporosis development?

      ea0049ep232
    • The effect of mechanical assisted squat exercise on pulmonary function, muscle mass and function with or without sarcopenia

      ea0049ep233
    • Beta-2 adrenergic receptor (ADRB2) gene polymorphism Arg16Gly as risk factor for osteoporosis

      ea0049ep234
    • Bone histomorphometry and bone marrow adipocytes in premenopausal women with type 2 diabetes

      ea0049ep235
    • Differences in bone strength and metabolic parameters according to the presence of hyperadiponectinemia and obesity in Korean adults: The KoGES- ARIRANG study

      ea0049ep236
    • Do the surgical outcomes change if the surgeon accompanies the endocrinologist during the preoperative ultrasonography examination?

      ea0049ep237
    • Teriparatide discontinuation in a patient with post surgical hypoparathyroidism: a clinical challenge

      ea0049ep238
    • Endocrine disorders in treatment-naive male patients with HIV infection

      ea0049ep239
    • Trabecular bone score is negatively associated with bone resorbtion markers in patients with primary hyperparathyroidism

      ea0049ep240
    • Normocalcemic primary hyperparathyroidism (NPH)

      ea0049ep241
    • Secondary hyperparathyroidism and its implication on bone mineral density in patients with different stages of chronic kidney disease

      ea0049ep242
    • Impact of vitamin D on the bone quality assessed by trabecular bone score in men

      ea0049ep243
    • Neutrophil lymphocyte ratio in 6 month teriparatide therapy of osteoporosis

      ea0049ep244
    • Analysis of DXA scans of males performed in clinical center of vojvodina

      ea0049ep245
    • Biological assessment and causes of secondary osteoporosis

      ea0049ep246
  • Calcium & Vitamin D metabolism
  • • Management with Cinacalcet of non-surgical primary hyperparathyroidism in the elderly.

      ea0049ep247
    • Glucocorticoids regulate expression of lung calbindin-D9k in mouse

      ea0049ep248
    • Vitamin D intoxication caused hypercalcemia: Case report

      ea0049ep249
    • Abstract unavailable

      ea0049ep250
    • Gitelman syndrome and primary hyperparathyroidism - a rare association

      ea0049ep251
    • The volume of parathyroid adenoma is related to presurgical PTH and 25OH-D3, but not calcium levels at patients with primary hyperparathyroidism

      ea0049ep252
    • Pseudohypoparathyroidism type Ib: a case of chronic severe hypocalcaemia and seizures diagnosed in adulthood

      ea0049ep253
    • A practice review of the use of cinacalcet in primary hyperparathyroidism

      ea0049ep254
    • Is there a threshold of Vitamin D sufficiency that can prevent secondary hyperparathyroidism?

      ea0049ep255
    • Spontaneous remission of parathyroid adenoma due to parathyroid apoplexy: a case report

      ea0049ep256
    • Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: a comparative study

      ea0049ep257
    • Parathyroid carcinoma: experience of a Portuguese centre

      ea0049ep258
    • Vitamin D prescribing bias in liver transplant referrals

      ea0049ep259
    • How to differentiate primary hyperparathyroidism with D hypovitaminosis from secondary hyperparathyroidism due to D hypovitaminosis?

      ea0049ep260
    • Pseudohypoparathyroidism as an etiological cause for epilepsy: a case report

      ea0049ep261
    • Long standing primary hyperparathyroidism consequences after parathyroid surgery: fast recovery not only for bone mass

      ea0049ep262
    • Associations of nitric oxide with vitamin D and other serological factors in healthy adolescents

      ea0049ep263
    • Primary hyperparathyroidism in pregnancy

      ea0049ep264
    • Eucalcemic parathyroid hormone elevation after parathyroid surgery for sporadic primary hyperparathyroidism

      ea0049ep265
    • Primary hyperparathyroidism mimicking metastatic bone disease

      ea0049ep266
    • Acute pancreatitis as the first presentation of primary hyperparathyroidism

      ea0049ep267
    • Gender difference in clinical presentation of primary hyperparathyroidism

      ea0049ep268
    • Prevalence of hypocalcemia in adults in Minsk, Belarus

      ea0049ep269
    • Assessment of changing in the therapeutic attitude in patients with primary hyperparathyrodism in conservative management after the realization of radial densitometry

      ea0049ep270
    • A rare case: intrathymic parathyroid adenoma

      ea0049ep271
    • Audit of emergency hypercalcaemia management in the acute medical unit

      ea0049ep272
    • Higher circulating parathyroid hormone concentration fascilitates preoperative diagnostic imagings for localization in primary hyperparathyroidism

      ea0049ep273
    • Calcifediol is more effective than cholecalciferol in the treatment of severe vitamin D deficiency in a patient submitted to malabsorbitive bariatric surgery: a case report

      ea0049ep274
    • The effect of 1,25(OH)2D3 on interferon i secretion by human mononuclear cells in vitro

      ea0049ep275
    • The changing face of primary hyperparathyroidism

      ea0049ep276
    • Single center experience of intact parathyroid hormone determination in washout samples of suspicious parathyroid adenomas

      ea0049ep277
    • Primary hyperparathyroidism due to atypical adenoma: clinical, biochemical and histological features of an Italian cohort

      ea0049ep278
    • Medullary vertebral compression in primary hyperparathyroidism

      ea0049ep279
    • Management of primary hyperparathyroidism: Experience of a large UK teaching hospital

      ea0049ep280
    • Fahr Syndrome and idiopathic primary hipoparathyroidism - clinical case

      ea0049ep281
    • Clinical presentations of four patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumor syndrome

      ea0049ep282
    • When is it worthwhile to perform parathyroid SPECT/CT scintigraphy in primary hyperparathyroidism?

      ea0049ep283
    • Parathormone (PTH) as a marker of vitamin D (VitD) deficiency

      ea0049ep284
    • Pathological basal ganglia calcification in isolated idiopathic hypoparathyroidism: a case report

      ea0049ep285
    • Diseases associated with hypercalcemia

      ea0049ep286
    • PTH levels in vitamin D deficiency

      ea0049ep287
    • Renal complications in patients with chronic postoperative hypoparathyroidism treated with oral calcium and active vitamin D metabolites

      ea0049ep288
    • The results of parathormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas for focused parathyroidectomy in patients with negative or suspicious sestamibi scans

      ea0049ep289
    • Weight has a weak influence on calcium-phosphorus metabolism in HIV-patients with vitamin d deficiency

      ea0049ep290
    • Chronic hypoparathyroidism disease profile from 492 patients in the PARADIGHM™ natural history global registry

      ea0049ep291
    • Prevalence of cardiometabolic risk factors among Saudi Women with vitamin D deficiency

      ea0049ep292
    • 18F-choline PET/MRI in patients with primary hyperparathyroidism and negative sestamibi SPECT/CT - report of two cases

      ea0049ep293
    • Severe hypocalcemia induced by Denosumab in a patient with Osteroporosis after malabsorptive bariatric surgery

      ea0049ep294
    • Performance characteristics of a new Waters MassTrak™ Vitamin D assay

      ea0049ep295
    • Vitamin D intoxication complicated with parathormon treatment in elderly: a case report

      ea0049ep296
    • Tc-99m sestamibi uptake by brown tumours in a patient with primary hyperparathyroidism

      ea0049ep297
    • Thyroid supression in patients with primary hyperparathyroidism may improve pre-surgical scintigraphy localisation

      ea0049ep298
    • Serum vitamin D in overweight patients with normal and impaired GFR

      ea0049ep299
    • The importance of ultrasound in the preoperative evaluation of patients with primary hyperthyroidism: a case report

      ea0049ep300
    • Abstract unavailable

      ea0049ep301
    • Ectopic production of calcitriol by non-hodgkin lymphoma as a cause of hypercalcemia: case report

      ea0049ep302
    • Primary hyperparathyroidism: elective parathyroidectomy versus conservative management; results of a retrospective cohort study

      ea0049ep303
    • Calcium metabolism and autoimmune thyroiditis

      ea0049ep304
    • Pseudohypoparathyroidism (PHP) and GNAS gene mutations - clinical spectrum from PHP type 1a to pseudopseudohypoparathyroidism

      ea0049ep305
    • Hyperparathyroidism and cardiovascular risk

      ea0049ep306
    • Risk factors associated with osteoporosis in beta-thalassaemia major patients

      ea0049ep307
    • Giants walk amongst us

      ea0049ep308
    • Hungry bone syndrome after treatment of severe primary hyperparathyroidism

      ea0049ep309
    • Clinical review of nine cases of pseudohypoparathyroidism

      ea0049ep310
    • Severe hypercalcemia revealing an atypical parathyroid adenoma

      ea0049ep311
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Hypercalcemia and cardiovascular disease

      ea0049ep312
    • Vitamin D levels in obese adults and cardiovascular risk

      ea0049ep313
  • Clinical case reports - Pituitary/Adrenal
  • • Partial gigantism: case report

      ea0049ep314
  • Clinical case reports - Thyroid/Others
  • • An unique case of celiac disease with hypocoagulation and secondary hyperparathyreodism in elderly patient - a case report

      ea0049ep315
    • Optic neuritis as presenting complaint in primary hypoparathyroidism

      ea0049ep316
    • The parathyroid carcinoma in a young adult male

      ea0049ep317
    • Clinical case of atypical parathyroid adenoma with severe hypercalcemia and multiple fragility fractures

      ea0049ep318
    • Congenital fibrous dysplasia and Klinefelter syndrome: coincidence or not?

      ea0049ep319
    • Parathyroid nodular hyperplasia: when imaging exams fail

      ea0049ep320
    • As clear as mud: an atypical case of primary hyperparathyroidism

      ea0049ep321
    • Familial hypocalciuric hypercalcemia with a new heterozygous missense mutation of CaSR gene and cinacalcet treatment

      ea0049ep322
    • Parathyroid carcinoma can be misdiagnosis with medullary thyroid cancer: how is that possible?

      ea0049ep323
    • Clinical case of pachydermoperiostosis

      ea0049ep324
    • Vascular dementia in a 57-year old woman with adenoma of parathyroid gland

      ea0049ep325
    • Equivocal preoperative imaging including 18F-fluorocholine PET-CT in primary hyperparathyroidism and nodular thyroid disease - case report

      ea0049ep326
    • Parathyroid carcinoma: a report of cases

      ea0049ep327
    • A rare case of giant parathyroid adenoma: diagnostic and therapeutic aspects

      ea0049ep328
    • Autosomal dominant hypocalcemia in a Portuguese family: novel mutation in the calcium-sensing receptor gene

      ea0049ep329
    • A case of intrathyroidal parathyroid adenoma presented with severe 25(OH)D3 deficiency, bone pain and high PTH

      ea0049ep330
    • The rare cause of primary hyperparathyroidism: Parathyroid Carcinoma

      ea0049ep331
    • A parathyroid adenoma presented with diffuse bone lesions and anemia

      ea0049ep332
    • Common bone lesions may be a sign of parathyroid carcinoma in the primary hyperparathyroidism

      ea0049ep333
    • Broken bones and blindness- a rare cause of osteoporosis

      ea0049ep334
    • An usual cause of post operative hypocalcemia

      ea0049ep335
    • Brown tumor in a normocalcemic patient

      ea0049ep336
    • Symptomatic bisphosphonate-induced hypocalcaemia after severe idiopathic hypercalcaemia

      ea0049ep337
    • Transient hyperglycemia during the course of primary hypoparathyroidism: Case study

      ea0049ep338
    • Hyperparathyroidism jaw tumour syndrome (HPT-JT)

      ea0049ep339
    • Fahr syndrome revealing a pseudohypoparathyroidism

      ea0049ep340
    • Parathyroid cyst: the forgotten diagnosis of a neck mass

      ea0049ep341
    • [ldquo]Pseudo or not[rdquo]: differential diagnosis of hyperparathyroidism with severe electrolyte imbalance in transgender patient: a challenging case report

      ea0049ep342
  • Developmental endocrinology
  • • Adolescent onset distal renal tubular acidosis presenting with significant growth retardation without rickets

      ea0049ep343
  • Endocrine tumours and neoplasia
  • • Differential roles of carboxylated and uncarboxylated Osteocalcin in stage I breast cancer as a diagnostic biomarker

      ea0049ep344
    • Gross CDC73 deletions in young patients with primary hyperparathyroidism in Russia

      ea0049ep345
    • Multiple endocrine neoplasia type 1 phenocopies: role of the genes associated with familial primary hyperparathyroidism

      ea0049ep346
    • Recurrent ectopic parathyroid carcinoma

      ea0049ep347
    • Exome analysis of a large family with familial isolated primary hyperparathyroidism (FIHP) and multiple cancers

      ea0049ep348
    • Parathyroid cancer - clinical presentation, prognostic factors and long-term evolution

      ea0049ep349
    • A suspicious case of multiple endocrine neoplasia

      ea0049ep350
  • Endocrine tumours and neoplasia (1)
  • • Bone mineral density in obese children

      ea0049ep351
  • Paediatric endocrinology
  • • Progressive osseous heteroplasia in a child with pseudohypoparathyroidism type I

      ea0049ep352
  • Steroid metabolism + action
  • • Genetic variations in the HSD11B1 gene in patients treated with glucocorticoids show associations with bone mineral density

      ea0049ep353
• Eposter Presentations: Diabetes, Obesity and Metabolism
• • Calcium & Vitamin D metabolism
  • • Abstract unavailable

      ea0049ep354
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Metabolic syndrome in digestive neoplasms

      ea0049ep355
    • Dyslipidemia-associated skin lesions as a short key for etiology unraveling and management of life-threatening acute pancreatitis in young male

      ea0049ep356
    • Metformin and changes in blood pressure and heart rate in lean patients with polycystic ovary syndrome (PCOS)- preliminary study

      ea0049ep357
    • Screening for type 2 diabetes mellitus as a method of secondary prevention of cardiovascular lesions

      ea0049ep358
    • Soybean phytoestrogens reduce 27-hydroxycholesterol concentration in the liver of middle-aged female rats

      ea0049ep359
    • Awareness and prevalence of metabolic syndrome among high-risk individuals attending internal medicine clinics across Jordan

      ea0049ep360
    • Nine months of practice in California - self-referrals in endocrinology

      ea0049ep361
    • Identifiying underdiagnosed or undertreated patients with familial hypercholesterolemia from the central laboratory registries

      ea0049ep362
    • The effect of admission hyperglycemia on clinical outcome of ischaemic stroke patients

      ea0049ep363
    • Deleting genomic region of Hsd17b1 in mice results into a hypomorphic Naglu allele, and consequently to a phenotype mimicking a lysosomal storage disease

      ea0049ep364
    • Salivary lactate levels during anaerobic threshold (AT) training

      ea0049ep365
    • The effect of tocilizumab - an interleukin-6 receptor antagonist - on lipid levels in rheumatoid arthritis

      ea0049ep366
    • Homocystein-significant marker of metabolic syndrome and atherosclerosis risk

      ea0049ep367
    • Graft vs host disease and insulin resistance after bone marrow transplantation

      ea0049ep368
    • Coronary artery calcium score in prediabetes - preliminary results

      ea0049ep369
    • Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance

      ea0049ep370
    • Metformin and changes in serum lipid profile in lean patients with polycystic ovary syndrome (PCOS)

      ea0049ep371
    • Prevalence of major cardiovascular risk factors among people living with HIV in a low risk country for cardiovascular disease

      ea0049ep372
    • The role of leptin signalling in the development of cardiovascular diseases in obesity

      ea0049ep373
    • Influence factors on lipid profile among patients with rheumatoid arthritis

      ea0049ep374
    • Abstract unavailable

      ea0049ep375
    • Oxidative stress and metabolic profiles assessment after melatonin and irbesartan co-administration in a novel pharmaceutical formulation

      ea0049ep376
    • The dual FXR/TGR5 agonist INT-767 counteracts nonalcoholic steatohepatitis and visceral adipose tissue dysfunction in a rabbit model of high fat diet-induced metabolic syndrome

      ea0049ep377
    • Prevalence of metabolic syndrome and its relation to physical activity and nutrition in Azerbaijan

      ea0049ep378
    • Isolated low HDL-Cholesterol in patients with type 2 diabetes about 168 cases

      ea0049ep379
    • Can hypoglycemic episodes in type 1 diabetics trigger cardiac arrhythmias?

      ea0049ep380
    • Family hypercholesterolemia: about 4 cases

      ea0049ep381
    • Description of an educational intervention lifestyle program in reducing cardiovascular risk factors

      ea0049ep382
    • Role of lactate dehydrogenase-A (LDH-A) in atherosclerosis

      ea0049ep383
  • Clinical case reports - Pituitary/Adrenal
  • • Prediction of type 1 diabetes in autoimmune polyglandular syndrome type 2

      ea0049ep384
  • Clinical case reports - Thyroid/Others
  • • Insulin autoimmune syndrome (Hirata Disease) triggered by a tyrosine kinase inhibitor drug in a Latin American patient

      ea0049ep385
    • Fulminant diabetic ketoacidosis complicating nivolumab immunotherapy

      ea0049ep386